Ndc 76385-102-01 Primaquine Phosphate Tablets, Usp 26.3 mg (=15 mg Base) (Primaquine Po4 26 3mg 1)
This is a description of Primaquine Phosphate USP tablets, manufactured by Bayshore Pharmaceuticals LLC. The tablets are round and purple in color, with "BY 4" imprinted on one side. They contain Primaquine Phosphate USP at 26.3mg and Primaquine Base at 15mg, and are film-coated. The tablets are packaged with cautionary labeling and require a prescription from a doctor. The tablets should be taken every hour for a specified duration, as directed by a physician. The prescription medication is intended for use by patients only and must be kept out of reach of children. The medication should be stored under controlled conditions at 20-25°C (68-77°F) until the expiration date printed on the container.*